The role of titin in muscular disorders

Annals of Medicine

Volumn 35, Issue 6, 2003, Pages 434-441

  Hackman, J Peter V ^a   Vihola, Anna K ^b   Udd, A Bjarne ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Cardiomyopathy; DCM; HCM; LGMD2J; Myopathy; Tibial muscular dystrophy; Titin; Titinopathy; TMD

Indexed keywords

CONNECTIN;

GENE MUTATION; GENE SILENCING; HEART DILATATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE DISEASE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; CHROMOSOMES, HUMAN, PAIR 2; DISEASE MODELS, ANIMAL; EXONS; HUMANS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUSCULAR DYSTROPHIES; MUTATION; PROTEIN KINASES;

EID: 0141924531     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310012797     Document Type: Review

References (78)

1. Trinick J. Titin and nebulin: protein rulers in muscle? Trends Biochem Sci 1994; 19: 405-9.
2. Labeit S, Kolmerer B. Titins: Giant proteins in charge of muscle ultrastructure and elasticity. Science 1995; 270: 293-6.
3. Labeit S, Kolmerer B, Linke W. The giant protein titin - emerging roles in physiology and pathophysiology. Circ Res 1997; 80: 290-4.
4. 2 Terminus of Titin Spans the Z-disc: Its interaction with a novel 19-kD ligand (T-cap) is required for sarcomeric integrity. J Cell Biol 1998; 143: 1013-27.
5. Trinick J, Tskhovrebova L. Titin: a molecular control freak. Trends Cell Biol 1999; 9: 377-80.
6. Liversage AD, Holmes D, Knight PJ, Tskhovrebova L, Trinick J. Titin and the sarcomere symmetry paradox. J Mol Biol 2001; 305: 401-9.
7. Knupp C, Luther PK, Squire JM. Titin organisation and the 3D architecture of the vertebrate-striated muscle I-band. J Mol Biol 2002; 322: 731-9.
8. Granzier H, Labeit S. Cardiac titin: an adjustable multi-functional spring. J Physiol 2002; 541: 335-42.
9. Freiburg A, Trombitas K, Hell W, Cazorla O, Fougerosse F, Centner T, et al. Series of exon-skipping events in the elastic spring region of titin as the structural basis of myofibrillar elastic diversity. Circ Res 2000; 86: 1114-21.
10. Gutierrez-Cruz G, Van Heerden A, Wang K. Modular motif, structural folds and affinity profiles of PEVK segment of human skeletal muscle titin. J Biol Chem 2001; 276: 7442-9.
11. Greaser M. Identification of new repeating motifs in titin. Proteins 2001; 43: 145-9.
12. Oberman WMJ, Gautel M, Weber K, Fürst DO. Molecular structure of the sarcomeric M-band: mapping of titin and myosin binding domains in myomesin and the identification of a potential regulatory phosphorylation site in myomesin. EMBO J 1997; 16: 211-20.
13. Bang M-L, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, et al. The complete gene sequence of titin, expression of an unusual 700-kDa titin isoform and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ Res 2001; 89: 1065-72.
14. Gautel M, Goulding D, Bullard B, Weber K, Fürst DO. The central Z-disk region of titin is assembled from a novel repeat in variable copy numbers. J Cell Sci 1996; 109: 2747-54.
15. Sorimachi H, Freiburg A, Kolmerer B, Ishiura S, Stier G, Gregorio CC, et al. Tissue-specific expression and a-Actinin binding properties of the Z-disc titin: Implications for the nature of vertebrate Z-discs. J Mol Biol 1997; 270: 688-95.
16. Trombitas K, Wu Y, Labeit S, Granzier H. Cardiac titin isoforms are expressed in the half-sarcomere and extend independently. J Physiol Heart Circ Physiol 2001: H1793-9.
17. Wu Y, Bell SP, Trombitas K, Witt CC, Labeit S, LeWinter MM, et al. Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness. Circulation 2002; 106: 1384-9.
18. Kolmerer B, Olivieri N, Witt CC, Herrmann BG, Labeit S. Genomic organization of M line titin and its tissue-specific expression in two distinct isoforms. J Mol Biol 1996; 256: 556-63.
19. Grove BK, Kurer V, Lehner C, Doetschman TC, Perriard J-C, Eppenberger HM. A new 185,000-dalton skeletal muscle protein detected by monoclonal antibodies. J Cell Biol 1984; 98: 518-24.
20. Labeit S, Gautel M, Lakey A, Trinick J. Towards a molecular understanding of titin. EMBO J 1992; 11: 1711-6.
21. Freiburg A, Gautel M. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem 1996; 235: 317-23.
22. Young P, Ferguson C, Bañuelos S, Gautel M. Molecular structure of the sarcomeric Z-disk: two types of titin interactions lead to an asymmetrical sorting of α-actinin. EMBO J 1998; 17: 1614-24.
23. Mues A, Young P, Fürst DO, Wilmanns M, Gautel M. Structural basis for activation of the titin kinase domain during myofibrillogenesis. Nature 1998; 395: 863-9.
24. Zou P, Gautel M, Geerlof A, Wilmanns M, Koch MHJ, Svergun DI. Solution scattering suggests cross-linking function of telethonin in the complex with titin. J Biol Chem 2003; 278: 2636-44.
25. Kulke M, Fujita-Becker S, Rostkova E, Neagoe C, Labeit D, Manstein DJ, et al. Interaction between PEVK-titin and actin filaments: origin of a viscous force component in cardiac myofibrils. Circ res 2001; 89: 874-81.
26. Ma K, Wang K. Interaction of nebulin SH3 domain with titin PEVK and myopalladin: implications for the signaling and assembly role of titin and nebulin. FEBS Letters 2002; 532: 273-8.
27. Sorimachi H, Kinbara K, Kimura S, Takahashi M, Ishiura S, Sasagawa N, et al. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J Biol Chem 1995; 270: 31158-62.
28. Gautel M, Mues A, Young P. Control of sarcomeric assembly: the flow of information on titin. Rev Physiol Biochem Pharmacol 1999; 38: 97-137.
29. Olson NJ, Pearson RB, Needleman DS, Hurwitz MY, Kemp BE, Means AR. Regulatory and structural motifs of chicken gizzard myosin light chain kinase. Proc Natl Acad Sci USA 1990; 87: 2284-8.
30. Mues A, van der Ven PFM, Young P, Fürst DO, Gautel M. Two immunoglobulin-like domains of the Z-disc portion of titin interact in a conformation-dependent way with telethonin. FEBS Lett 1998; 428: 111-4.
31. Flaherty D, Gernert K, Schmeleva N, Tang X, Mercer K, Borodovsky M, et al. Titin in C. elegans with unusual features: Coiled-coil domains, novel regulation of kinase activity and two new possible elastic regions. J Mol Biol 2002; 323: 533-49.
32. Spencer JA, Eliazer S, Ilaria RL, Richardson JA, Olson EN. Regulation of microtubule dynamics differentiation by MURF, a striated muscle RING-Finger Protein. J Cell Biol 2000; 150: 771-84.
33. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294: 1704-8.
34. McElhinny AS, Kakinuma K, Sorimachi H, Labeit S, Gregorio CC. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J Cell Biol 2002; 157: 125-36.
35. Pizon V, Iakovenko A, van der Ven PFM, Kelly R, Fatu C, Fürst DO, et al. Transient association of titin and myosin with microtubules in nascent myofibrils directed by the MURF2 RING-finger protein. J Cell Sci 2002; 115: 4469-82.
36. Oberman W, Gautel M, Weber K, Fürst DO. Molecular structure of the sarcomeric M-band: mapping of titin and myosin binding domains in myomesin and the identification of a potential regulatory phosphorylation site in myomesin. EMBO J 1997; 16: 211-20.
37. Centner T, Yano J, Kimura E, McElhinny AS, Pelin K, Witt CC, et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J Mol Biol 2001; 306: 717-26.
38. th ENMC workshop: pathogenesis in the non-sarcoglycan limb-girdle muscular dystrophies, Naarden, April 12-14, 2002, Neuromusc Disord 2003; 13: 80-90.
39. Young P, Ehler E, Gautel M. Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly. J Cell Biol 2001; 154: 123-36.
40. Neuromuscular disorders: gene location. Neuromusc Disord 2003; 13: 97-8.
41. Udd B, Kääriäinen H, Somer H. Muscular dystrophy with separate clinical phenotypes in a large family. Muscle Nerve 1991; 14: 1050-8.
42. Udd B, Rapola J, Nokelainen P, Arikawa E, Somer H. Non-vacuolar myopathy in a large family with both late adult onset distal myopathy and severe proximal muscular dystrophy. J Neurol Sci 1992; 113: 214-21.
43. Udd B, Partanen J, Halonen P, Falck B, Hakamies L, Heikkilä H, et al. Tibial muscular dystrophy - late adult-onset distal myopathy in 66 finnish patients. Arch Neurol 1993; 50: 604-8.
44. Haravuori H, Mäkelä-Bengs P, Udd B, Partanen J, Pulkkinen L, Somer H, et al. Assignment of the tibial muscular dystrophy locus to chromosome 2q31. Am J Hum Genet 1998; 62: 620-6.
45. Udd B, Haravuori H, Kalimo H, Partanen J, Pulkkinen L, Paetau A, et al. Tibial muscular dystrophy - from clinical description to linkage on chromosome 2q31. Neuromusc Disord 1998; 8: 327-32.
46. Markesbery WR, Griggs RC, Leach RP, Laphom LW. Late onset hereditary distal myopathy. Neurology 1974; 23: 127-34.
47. de Seze J, Udd B, Haravuori H, Sablonniere B, Maurage CA, Hurtevent JF, et al. The first European family with tibial muscular dystrophy outside the Finnish population. Neurology 1998; 51: 1746-8.
48. Van den Bergh P, Bouquiaux O, Verellen C, Marchand S, Richard I, Hackman P, et al. Tibial muscular dystrophy in a Belgian family. Annals of Neurology 2003: in press.
49. Chadwick RB, Conrad MP, McGinnis MD, Johnston-Dow L, Spurgeon SL, Kronick MN. Heterozygote and mutation detection by direct automated fluorescent DNA sequencing using a mutant Taq DNA polymerase. Biotechniques 1996; 20: 676-83.
50. Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, de Seze J, et al. Tibial muscular dystrophy (TMD) is a titinopathy - caused by mutations in TTN, the gene encoding the giant skeletal muscle protein titin. Am J Hum Genet 2002; 71: 492-500.
51. Improta S, Politou AS, Pastore A. Immunoglobulin-like modules from titin I-band: extensible components of muscle elasticity. Structure 1996; 4: 323-37.
52. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-402.
53. Haravuori H, Vihola A, Straub V, Auranen M, Richard I, Marchand S, et al. Secondary calpain3 deficiency in 2q-linked muscular dystrophy: Titin is the candidate gene. Neurology 2001; 56: 869-77.
54. Vidal-Puig A, Moller DE. Comparative sensitivity of alternative single strand conformation polymorphism (SSCP) methods. Biotechniques 1994; 17: 490-6.
55. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, et al. Mutations in the proteolytic enzyme calpain cause limb-girdle muscular dystrophy type 2A. Cell 1995; 81: 27-40.
56. Richard I, Roudaut C, Marchand S, Baghdiguian S, Herasse M, Stockholm D, et al. Loss of calpain3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IκBα/nuclear factor κB pathway perturbation in mice. J Cell Biol 2000; 151: 1583-90.
57. Fardeau M, Eymard B, Mignard C, Tomé FMS, Richard I, Beckmann J. Chromosome 15-linked limb girdle muscular dystrophy - clinical phenotype. Neuromusc Disord 1996; 6: S7.
58. Fougerousse F, Anderson LVB, Delezoide A-L, Suel L, Durand M, Beckmann JS. Calpain3 expression during human cardiogenesis. Neuromusc Disord 2000; 10: 251-6.
59. Li D, Tapscoft T, Gonzales O, Burch P E, Quinones MA, Zoghbi WA, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999; 100: 461-4.
60. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, et al. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. New Eng J Med 1993; 329: 921-5.
61. Olson T M, Michels V, Thibodeau S N, Tai Y S, Keating M T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998; 280: 750-2.
62. Kamisago M, Sharma S D, DePalma S R, Solomon S, Sharma P, McDonough B, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. New Eng J Med 2000; 343: 1688-96.
63. Norgett E, Hatsell S J, Carvajal-Huerta L, Cabezas J C, Common J, Purkis PE, et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet 2000; 9: 2761-6.
64. Tsubata S, Bowles K R, Vatta M, Zintz C, Titus J, Muhonen L, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000; 106: 655-62.
65. Knöll R, Hoshijima M, Hoffmann HM, Person V, Lorenxzen-Schmidt I, Bang M-L, et al. The cardiac mechanical stretch machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002; 111: 943-55.
66. Siu BL, Niimura H, Osborne JA, Fatkin D, MacRae C, Solomon S, et al. Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation 1999; 99: 1022-6.
67. Gerull B, Gramlich M, Atherton J, McNabb M, Trombitás K, Sasse-Klaassen S, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002; 30: 201-4.
68. Itoh-Satoh M, Hayashi T, Nishi H, Koga Y, Arimura T, Koanagi T, et al. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun 2002; 291: 385-93.
69. Gotthardt M, Hammer R, Hübner N, Monti J, Witt CC, McNabb M, et al. Conditional expression of mutant M-line titins result in cardyomyopathy with altered sarcomere structure. J Biol Chem 2003; 278: 6059-65.
70. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene. Bioch Biophys Res Comm 1999; 262: 411-7.
71. Seidman JG, Seidmann C. The genetics basis for cardiomyopathy: From mutation identification to manifestation paradigms. Cell 2001; 104: 557-67.
72. Burggren WW, Pindner AW. Ontogeny of cardiovascular and respiratory physiology in lower vertebrates. Annu Rev Physiol 1991; 53: 107-35.
73. Xu X, Meiler SE, Zhong TP, Mohideen M, Crosley DA, Burggren WW, et al. Cardiomyopathy in zebrafish due to mutation in alternatively spliced exon of titin. Nat Genet 2002; 30: 205-9.
74. Siracusa LD, Silan CM, Justice MJ, Mercer JA, Bauskin AR, Ben-Neriah Y, et al. A molecular genetic linkage map of mouse chromosome 2. Genomics 1990; 6: 491-504.
75. Müller-Seitz M, Kaupmann K, Labeit S, Jockush H. Chromosomal localization of the mouse titin gene and its relation to "muscular dystrophy with myositis" and nebulin genes on chromosome 2. Genomics 1993; 18: 559-61.
76. Garvey SM, Rajan C, Lerner AP, Frankel WN, Cox GA. The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin. Genomics 2002; 79: 146-9.
77. Mayans O, van der Ven PFM, Wilm M, Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain3 cause limb-girdle muscular dystrophy type 2A. Cell 1998; 81: 27-40.
78. Lange S, Auerbach D, Mcloughlin P, Perriard E, Schäfer BW, Perriard JC, et al. Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/ FHL-2. J Cell Sci 2002; 115: 4925-36.